11 Mar Cellular Origins
Dan Strange, Ph.D., Chief Technology Officer
April 28 | 1:30pm | Salone dei Cavalieri, Section 1
Cambridgeshire, UK
(Private)
Cellular Origins is enabling the manufacture of cell therapies at scale. With a flexible, scalable, factory-led approach, Cellular Origins has overcome the unique challenges of cell therapy manufacturing, unlocking access to the same advanced automation that has driven scale in logistics, automotive, and silicon fabrication industries. Cellular Origins’ platform, Constellation, combines mobile robotics and AI with proven bioprocess instruments, providing end-to-end manufacturing, eliminating therapy redevelopment, and speeding up clinical-to-commercial timelines. Cellular Origins is trusted by market leaders such as J&J, Cytiva, Fresenius Kabi, Thermo Fisher Scientific, and Wilson Wolf. Constellation orchestrates seamless automation of existing workflows, reliably scaling manufacture to enable the production of 100,000s of doses of transformative therapies.
